Sumitomo Life Insurance Co. purchased a new position in Cigna Group (NYSE:CI – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 3,259 shares of the health services provider’s stock, valued at approximately $898,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of CI. Assetmark Inc. boosted its position in shares of Cigna Group by 10.0% during the 1st quarter. Assetmark Inc. now owns 65,662 shares of the health services provider’s stock worth $17,515,000 after acquiring an additional 5,963 shares in the last quarter. Mystic Asset Management Inc. acquired a new position in Cigna Group during the second quarter valued at approximately $2,808,000. HighTower Advisors LLC raised its position in Cigna Group by 402.7% during the second quarter. HighTower Advisors LLC now owns 354,398 shares of the health services provider’s stock valued at $97,701,000 after purchasing an additional 283,897 shares in the last quarter. KBC Group NV lifted its stake in Cigna Group by 6.4% during the second quarter. KBC Group NV now owns 380,034 shares of the health services provider’s stock worth $104,768,000 after purchasing an additional 22,978 shares during the last quarter. Finally, Handelsbanken Fonder AB lifted its stake in Cigna Group by 12.1% during the second quarter. Handelsbanken Fonder AB now owns 82,825 shares of the health services provider’s stock worth $22,833,000 after purchasing an additional 8,960 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.
Insider Transactions at Cigna Group
In other Cigna Group news, insider Nicole S. Jones sold 19,436 shares of the company’s stock in a transaction dated Tuesday, August 4th. The stock was sold at an average price of $276.27, for a total value of $5,369,583.72. Following the completion of the transaction, the insider owned 27,256 shares of the company’s stock, valued at $7,530,015.12. This represents a 41.63% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of Cigna Group stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 23,012 shares of company stock valued at $6,386,550. Insiders own 0.60% of the company’s stock.
Cigna Group Stock Performance
Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The company had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. During the same period in the prior year, the business earned $7.20 earnings per share. The company’s revenue for the quarter was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. On average, equities analysts forecast that Cigna Group will post 30.51 earnings per share for the current fiscal year.
Cigna Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. Cigna Group’s payout ratio is currently 25.82%.
Wall Street Analysts Forecast Growth
CI has been the topic of several recent analyst reports. Guggenheim lifted their price target on Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a research note on Friday, July 31st. Robert W. Baird set a $362.00 price objective on Cigna Group in a research report on Friday, July 31st. Raymond James Financial lowered Cigna Group from a “strong-buy” rating to an “outperform” rating and reduced their price objective for the company from $350.00 to $320.00 in a research note on Monday, August 3rd. Deutsche Bank Aktiengesellschaft cut Cigna Group from a “buy” rating to a “hold” rating and decreased their target price for the company from $303.00 to $302.00 in a research report on Wednesday, May 20th. Finally, Morgan Stanley boosted their target price on Cigna Group from $355.00 to $361.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 20th. Fifteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $339.45.
Read Our Latest Stock Analysis on Cigna Group
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Featured Stories
- Five stocks we like better than Cigna Group
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
